Literature DB >> 34982273

Novel molecules as the emerging trends in cancer treatment: an update.

Priyanka Sekar1, Raashmi Ravitchandirane1, Sofia Khanam2, Nethaji Muniraj3, Ananda Vayaravel Cassinadane4.   

Abstract

As per World Health Organization cancer remains as a leading killer disease causing nearly 10 million deaths in 2020. Since the burden of cancer increases worldwide, warranting an urgent search for anti-cancer compounds from natural sources. Secondary metabolites from plants, marine organisms exhibit a novel chemical and structural diversity holding a great promise as therapeutics in cancer treatment. These natural metabolites target only the cancer cells and the normal healthy cells are left unharmed. In the emerging trends of cancer treatment, the natural bioactive compounds have long become a part of cancer chemotherapy. In this review, we have tried to compile about eight bioactive compounds from plant origin viz. combretastatin, ginsenoside, lycopene, quercetin, resveratrol, silymarin, sulforaphane and withaferin A, four marine-derived compounds viz. bryostatins, dolastatins, eribulin, plitidepsin and three microorganisms viz. Clostridium, Mycobacterium bovis and Streptococcus pyogenes with their well-established anticancer potential, mechanism of action and clinical establishments are presented.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cancer; Combretastatin; Eribulin; Ginsenoside; Mycobacterium bovis; Novel molecules; Plitidepsin

Mesh:

Substances:

Year:  2022        PMID: 34982273     DOI: 10.1007/s12032-021-01615-6

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  199 in total

Review 1.  Plants as a source of anti-cancer agents.

Authors:  Gordon M Cragg; David J Newman
Journal:  J Ethnopharmacol       Date:  2005-08-22       Impact factor: 4.360

Review 2.  Gene therapy for cancer treatment: past, present and future.

Authors:  Deanna Cross; James K Burmester
Journal:  Clin Med Res       Date:  2006-09

Review 3.  Molecular targeted therapy: Treating cancer with specificity.

Authors:  Yeuan Ting Lee; Yi Jer Tan; Chern Ein Oon
Journal:  Eur J Pharmacol       Date:  2018-07-20       Impact factor: 4.432

4.  Biological research in the evolution of cancer surgery: a personal perspective.

Authors:  Bernard Fisher
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

5.  Cancer statistics, 2013.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2013-01-17       Impact factor: 508.702

Review 6.  Curative cancer chemotherapy.

Authors:  E Frei
Journal:  Cancer Res       Date:  1985-12       Impact factor: 12.701

7.  Tobacco carcinogen induces both lung cancer and non-alcoholic steatohepatitis and hepatocellular carcinomas in ferrets which can be attenuated by lycopene supplementation.

Authors:  Koichi Aizawa; Chun Liu; Sanyuan Tang; Sudipta Veeramachaneni; Kang-Quan Hu; Donald E Smith; Xiang-Dong Wang
Journal:  Int J Cancer       Date:  2016-05-14       Impact factor: 7.396

Review 8.  Cancer and radiation therapy: current advances and future directions.

Authors:  Rajamanickam Baskar; Kuo Ann Lee; Richard Yeo; Kheng-Wei Yeoh
Journal:  Int J Med Sci       Date:  2012-02-27       Impact factor: 3.738

Review 9.  Hormone Replacement Therapy in Cancer Survivors - Review of the Literature.

Authors:  Tamás Deli; Mónika Orosz; Attila Jakab
Journal:  Pathol Oncol Res       Date:  2019-01-08       Impact factor: 3.201

Review 10.  Cancer stem cell metabolism: target for cancer therapy.

Authors:  Young Chan Chae; Jae Ho Kim
Journal:  BMB Rep       Date:  2018-07       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.